| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4540 | S07662 | Inverse agonist of the constitutive androstane receptor (CAR) |
|
| DCC4541 | S-1033 | FP receptor agonist |
|
| DCC4542 | S-1360 | Novel HIV-1 integrase inhibitor |
|
| DCC4543 | s14161 | Novel inhibitor of D-cyclin transactivation via phosphoinositide 3-kinase pathway |
|
| DCC4544 | S14671 | Potent 5-HT1A receptor agonist, also acting as a 5-HT2A and 5-HT2C receptor antagonist |
|
| DCC4545 | S15535 | Potent, orally active, partial 5-HT1A receptor agonist |
|
| DCC4546 | s17834 | Inhibitor of NADPH oxidase, preventing the structural and functional sequelae of diet-induced metabolic heart disease |
|
| DCC4547 | S-18326 | Potent and selective thrombin inhibitor for the treatment of thromboembolic disorders |
|
| DCC4548 | S18327 | Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors |
|
| DCC4549 | S18616 Hydrochloride | Selective and highly potent alpha2-adrenoceptor agonist |
|
| DCC4550 | S1pr4-agonist-5c | Novel potent and selective agonist activity for S1PR4 |
|
| DCC4551 | S1r-in-10 | Novel selective sigma 1 receptor (S1R) antagonist, exhibiting potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slowing clearance in liver microsomes, and excellent blood-brain |
|
| DCC4552 | S23515 Hydrochloride | Potent and selective ligand of imidazoline 1 receptor (I1R) |
|
| DCC4553 | S23757 | Potent and selective ligand of imidazoline 1 receptor (I1R) |
|
| DCC4554 | S27847 | Potent activator of the AMP-activated protein kinase (AMPK) |
|
| DCC4555 | S32797 | Potent quinone reductase 2 (QR2) inhibitor |
|
| DCC4556 | S-34324 | alpha2-Adrenoceptor Antagonist, Norepinephrine Transporter (NET) Inhibitor, Serotonine Transporter (SERT) Inhibitor |
|
| DCC4557 | s3i-201.1066 | Potent and selective inhibitor of constitutive Stat3 DNA-binding and transcriptional activities |
|
| DCC4558 | S3qel-1 | Novel modulator of the retrograde signaling including cellular responses to hypoxic and oxidative stress, selectively eliminating superoxide production by complex III without altering oxidative phosphorylation |
|
| DCC4559 | S-4048 | Potent inhibitor of glucose-6-phosphate translocase (G6P T1) |
|
| DCC4560 | S-49164 | Novel glucokinase (GK) activator |
|
| DCC4561 | S-50612 | Novel glucokinase (GK) activator |
|
| DCC4562 | S-73362 | Dual PPARα/γ agonist |
|
| DCC4563 | S8155-7 | Novel Analogue of SUN-B8155, acting as a cell active and functionally-relevant agonist of calcitonin receptor (CTR), inducing different Gs or arrestin activities through CTR |
|
| DCC4564 | S-8510 Phosphate | Partial benzodiazepine inverse agonist, showing antidepressant-like pharmacological activity and acting as a cognitive enhancer |
|
| DCC4565 | S-8921 | Novel ileal Na /bile acid cotransporter inhibitor |
|
| DCC4566 | Sab378 | Peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibiting gastrointestinal motility with no effect on experimental colitis in mice |
|
| DCC4567 | Safrazine Hydrochloride | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC4568 | Sag1.5 | Novel Smoothened receptor agonist |
|
| DCC4569 | Saha-bpyne | Novel clickable HDAC inhibitor, selectively labeling HDAC complex proteins |
|
